RESISTANT HYPERTENSION – RAY OF HOPE
DOI:
https://doi.org/10.47144/phj.v46i1.604Keywords:
RESISTANT HYPERTENSION – RAY OF HOPEAbstract
Hypertension has assumed the status of a major health problem effecting 40%
population above the age of 60 years. The causal relationship with stroke, left
ventricular hypertrophy, heart failure and renal failure has been established
beyond any doubt. Adequate hypertension control remains a challenge even in
the advanced countries. Resistant hypertension, defined as failure to achieve
target blood pressure despite concurrent use of 3 antihypertensive agents of
different classes inclusive of diuretics, is estimated to affect 20-30% of
hypertensive patients.1,2
To conclude, resistant hypertension is a big challenge considering the high prevalence in middle aged and older population and it claims higher toll in terms of cardiovascular, cerebrovascular and renal complications. Sympathetic renal denervation has proven to be a ray of hope for such patients. It has been shown to reduce blood pressure in short term and confer additional benefits in many studies. The technology has to mature further so that it is available to larger population and at an affordable cost.
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/
